![Jean-Francois Leprince](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jean-Francois Leprince
Director Ejecutivo en GLyPharma Therapeutic, Inc. .
Cargos activos de Jean-Francois Leprince
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
GLyPharma Therapeutic, Inc.
![]() GLyPharma Therapeutic, Inc. BiotechnologyHealth Technology GLyPharma Therapeutic, Inc. develops oncology therapeutic treatment. It engages in the development of the clinical efficacy of FE 203799, a novel proprietary Glucagon-Like Peptide-2(GLP-2) analogue exerting unique pharmacological effects in a first-in-class, meaningful indication for patients with hematological malignancies receiving myelotoxic therapies. The company was founded in August 2012 and is headquartered in Montreal, Canada. | Director/Miembro de la Junta | - | - |
Director Ejecutivo | - | - | |
ILKOS THERAPEUTICS, Inc.
![]() ILKOS THERAPEUTICS, Inc. BiotechnologyHealth Technology ILKOS THERAPEUTICS, Inc. operates as biotechnology firm. It develops drug and clinical solutions for the treatment of venous lower limb ulcers. The company is headquartered in Laval, Canada. | Director/Miembro de la Junta | - | - |
CTI Capital, Inc.
![]() CTI Capital, Inc. Investment ManagersFinance CTI Capital, Inc. is a Venture Capital firm, a subsidiary of CTI Capital Groupe, Inc. founded in 1987. CTI Capital, Inc. is headquartered in Montréal. | Inversor de Capital Privado | - | - |
Historial de carrera de Jean-Francois Leprince
Antiguos cargos conocidos de Jean-Francois Leprince.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Hoechst Marion Roussel, Inc. | Presidente | 01/01/1998 | 01/01/2004 |
Aventis Pharmaceuticals, Inc.
![]() Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Presidente | 01/01/1998 | 01/01/2004 |
Benelux Real Estate AG
![]() Benelux Real Estate AG Real Estate DevelopmentFinance Part of AGIV Real Estate AG, Benelux Real Estate AG engages in real estate development. | Corporate Officer/Principal | 01/01/1979 | 01/01/2004 |
Somnus Therapeutics, Inc.
![]() Somnus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Somnus Therapeutics, Inc. operates as a pharmaceutical company. It develops therapeutics to address the need of insomnia patients. The company was founded by Gary C. Cupit in June 2007 is headquartered in Branchburg, NJ. | Director/Miembro de la Junta | - | - |
University of Montréal | Corporate Officer/Principal | 01/01/2004 | - |
Montréal International
![]() Montréal International Miscellaneous Commercial ServicesCommercial Services Montréal International attracts and promotes economic development of Greater Montreal. The company was founded in 1996 and is headquartered in Montréal, Canada. | Director/Miembro de la Junta | - | - |
░░░ ░░░░░░░░ ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Estadísticas
Internacional
Canadá | 7 |
Estados Unidos | 5 |
Alemania | 2 |
Operativa
Director/Board Member | 5 |
Corporate Officer/Principal | 3 |
President | 2 |
Sectorial
Health Technology | 5 |
Finance | 3 |
Commercial Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 10 |
---|---|
The Dow Chemical Co.
![]() The Dow Chemical Co. Chemicals: SpecialtyProcess Industries The Dow Chemical Co. engages in the manufacture and distribution of chemicals, plastics, industrial and agricultural products. It serves agriculture, automotive, building and construction, consumer, electronic materials, infrastructure, packaging, product finder and product safety industries. The company was founded by Herbert Henry Dow in 1897 and is headquartered in Midland, MI. | Process Industries |
Aventis Pharmaceuticals, Inc.
![]() Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
CTI Capital, Inc.
![]() CTI Capital, Inc. Investment ManagersFinance CTI Capital, Inc. is a Venture Capital firm, a subsidiary of CTI Capital Groupe, Inc. founded in 1987. CTI Capital, Inc. is headquartered in Montréal. | Finance |
Benelux Real Estate AG
![]() Benelux Real Estate AG Real Estate DevelopmentFinance Part of AGIV Real Estate AG, Benelux Real Estate AG engages in real estate development. | Finance |
Montréal International
![]() Montréal International Miscellaneous Commercial ServicesCommercial Services Montréal International attracts and promotes economic development of Greater Montreal. The company was founded in 1996 and is headquartered in Montréal, Canada. | Commercial Services |
Hoechst Marion Roussel, Inc. | |
GLyPharma Therapeutic, Inc.
![]() GLyPharma Therapeutic, Inc. BiotechnologyHealth Technology GLyPharma Therapeutic, Inc. develops oncology therapeutic treatment. It engages in the development of the clinical efficacy of FE 203799, a novel proprietary Glucagon-Like Peptide-2(GLP-2) analogue exerting unique pharmacological effects in a first-in-class, meaningful indication for patients with hematological malignancies receiving myelotoxic therapies. The company was founded in August 2012 and is headquartered in Montreal, Canada. | Health Technology |
ILKOS THERAPEUTICS, Inc.
![]() ILKOS THERAPEUTICS, Inc. BiotechnologyHealth Technology ILKOS THERAPEUTICS, Inc. operates as biotechnology firm. It develops drug and clinical solutions for the treatment of venous lower limb ulcers. The company is headquartered in Laval, Canada. | Health Technology |
Somnus Therapeutics, Inc.
![]() Somnus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Somnus Therapeutics, Inc. operates as a pharmaceutical company. It develops therapeutics to address the need of insomnia patients. The company was founded by Gary C. Cupit in June 2007 is headquartered in Branchburg, NJ. | Health Technology |
Chlorion Pharma, Inc.
![]() Chlorion Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Chlorion Pharma, Inc. Develops small molecule leads for the treatment of naturopathic pain and epilepsy. It develops therapeutics for the treatment of neuropathic pain and epilepsy. The company was founded by Jeffrey A. M. Coull, Yves De Koninck and Martin Gagnon in 2004 and is headquartered in Laval, Canada. | Commercial Services |